University Of Texas Md Anderson Cancer Center

	Symbol	Grade	Name	% Change
	TCRT	F	Alaunos Therapeutics, Inc.	2.38
	TAK	F	Takeda Pharmaceutical Company Limited	0.84

Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic

Symbol	Grade	Name	Weight
PPH	B	Market Vectors Pharmaceutical ETF	4.22
FLCO	B	Franklin Liberty Investment Grade Corporate ETF	1.02
GERM	D	ETFMG Treatments Testing and Advancements ETF	0.82
FLCB	B	Franklin Liberty U.S. Core Bond ETF	0.34
PTIN	C	Pacer Trendpilot International ETF	0.25

Compare ETFs

Date	Stock	Title
Apr 29	TAK	Down -6.19% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. (TAK) Looks Ripe for a Turnaround
Apr 26	TAK	Bristol, Sanofi, Takeda gain positive CHMP recommendations
Apr 26	TAK	Down -5.9% in 4 Weeks, Here's Why Takeda Pharmaceutical Co. (TAK) Looks Ripe for a Turnaround
Apr 26	TAK	HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
Apr 26	TAK	Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
Apr 25	TAK	Takeda said to have left industry trade group BIO
Apr 25	TAK	All You Need to Know About Takeda Pharmaceutical Co. (TAK) Rating Upgrade to Strong Buy
Apr 25	TAK	TAK or CTLT: Which Is the Better Value Stock Right Now?
Apr 25	TAK	20 Fastest Growing Health Tech Companies in the World
Apr 25	TAK	New Strong Buy Stocks for April 25th

University Of Texas Md Anderson Cancer Center: The University of Texas MD Anderson Cancer Center is a comprehensive cancer center located in Houston, Texas. It is one of the original three comprehensive cancer centers in the United States. MD Anderson is one of the nation’s top-ranked cancer hospitals and is dedicated to providing patient care, research, education, and prevention programs to help eliminate cancer. The center is affiliated with the University of Texas Health Science Center at Houston and is a part of the University of Texas System.